Researchers have discovered how specific versions of a protein called Numb protect the key tumor suppressor p53 from destruction. The study suggests that the loss of these particular Numb proteins makes breast cancers more aggressive and resistant to chemotherapy, but points the way toward new therapeutic approaches that could improve patient outcome by preserving p53 levels.